{
  "meta": {
    "title": "Adrenergic_Drugs",
    "url": "https://brainandscalpel.vercel.app/adrenergic-drugs-5ceb72dd.html",
    "scrapedAt": "2025-11-29T18:33:39.364Z"
  },
  "questions": [
    {
      "id": 3344,
      "choices": [
        {
          "id": 13355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erection</span></span></span></p>"
        },
        {
          "id": 13356,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation </span></span></span></p>"
        },
        {
          "id": 13357,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dilation of bronchus </span></span></span></p>"
        },
        {
          "id": 13358,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased cardiac contractility </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation primarily causes which of the following actions?<strong> </strong></span></span></span></p>",
      "unique_key": "Q2413333",
      "question_audio": null,
      "question_video": null,
      "map_id": 35890,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Erection</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The muscarinic receptors are a subset of acetylcholine receptors, which are stimulated by the neurotransmitter acetylcholine. Muscarinic receptors are associated with the parasympathetic nervous system, which is responsible for the &#39;rest and digest</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">functions of the body. Here&#39;s the explanation for each option:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Muscarinic receptor stimulation by the parasympathetic nervous system results in vasodilation and increased blood flow to erectile tissues, leading to an erection. This is an example of a cholinergic action where the neurotransmitter acetylcholine activates muscarinic receptor</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ejaculation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is primarily a function of the sympathetic nervous system, not muscarinic receptor stimulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dilation of bronchus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Muscarinic receptor stimulation actually leads to bronchoconstriction, not dilation. The dilation of bronchi is mediated by the sympathetic nervous system through &beta;2-adrenergic receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increased cardiac contractility:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is mainly mediated by &beta;1-adrenergic receptors under the influence of the sympathetic nervous system. Muscarinic receptor stimulation can decrease heart rate but does not directly increase contractility.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The parasympathetic nervous system, through muscarinic receptor stimulation, primarily causes erection due to vasodilation in erectile tissues, contrasting with the sympathetic nervous system&#39;s role in ejaculation.</span></span></span></p>",
      "correct_choice_id": 13355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3277,
      "choices": [
        {
          "id": 13087,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha agonist</span></span></span></p>"
        },
        {
          "id": 13088,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></span></span></p>"
        },
        {
          "id": 13089,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
        },
        {
          "id": 13090,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient present with diabetic macular edema with glaucoma. Which of the following drug should be avoided in this patient?</span></span></span></p>",
      "unique_key": "Q4795762",
      "question_audio": null,
      "question_video": null,
      "map_id": 35893,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues s</strong>hould be<strong> avoided in patients with diabetic macular edema </strong>because they can <strong>exacerbate</strong> the condition. These drugs, including <strong>Latanoprost and Bimatoprost, </strong>are known to <strong>potentially cause cystoid macular edema (CME)</strong>, which can <strong>worsen existing macular edema</strong> in<strong> diabetic patients. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha agonists: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These are<strong> not primarily </strong>associated with<strong> exacerbation of macular edema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acetazolamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;A<strong> carbonic anhydrase inhibitor, not </strong>typically associated with <strong>causing or worsening macular edema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Commonly used in glaucoma</strong> to <strong>reduce intraocular pressure</strong> without affecting macular edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues </strong>can <strong>worsen macular edema</strong> and therefore should be <strong>avoided in patients with diabetic macular edema. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Important<strong> adverse effects of anti-glaucoma drugs</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115656.jpg\" style=\"height:720px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8<sup>th</sup>/169</span></strong></span></span></p>",
      "correct_choice_id": 13090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3282,
      "choices": [
        {
          "id": 13107,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
        },
        {
          "id": 13108,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Noradrenaline</span></span></span></p>"
        },
        {
          "id": 13109,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
        },
        {
          "id": 13110,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following acts on &alpha;1, &alpha;2 and &beta;1 receptors but does not stimulate &beta;2 receptors?</span></span></span></p>",
      "unique_key": "Q7687229",
      "question_audio": null,
      "question_video": null,
      "map_id": 35895,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Noradrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline (norepinephrine) acts on &alpha;1, &alpha;2, and &beta;1 adrenergic receptors.</strong> It is a naturally occurring <strong>catecholamine </strong>that functions as a<strong> neurotransmitter and hormone in the body</strong>. Noradrenaline&#39;s action on <strong>&alpha;1 and &alpha;2 receptors</strong> is responsible for its <strong>vasoconstrictive effects</strong>, while its action on <strong>&beta;1 receptors</strong> affects <strong>cardiac output by increasing the heart rate </strong>and <strong>myocardial</strong> <strong>contractility.</strong> It <strong>does not stimulate &beta;2 receptors</strong>, which are primarily involved in <strong>bronchodilation and vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115834.jpg\" style=\"height:338px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 13108,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3302,
      "choices": [
        {
          "id": 13187,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchodilation by beta-2 receptors</span></span></span></p>"
        },
        {
          "id": 13188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiovascular effects of beta-1 receptors</span></span></span></p>"
        },
        {
          "id": 13189,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action on blood vessels by alpha-1 receptors</span></span></span></p>"
        },
        {
          "id": 13190,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action on presynaptic alpha-2 receptors</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of anaphylactic shock, which of the following action of adrenaline is not required? </span></span></p>",
      "unique_key": "Q5649357",
      "question_audio": null,
      "question_video": null,
      "map_id": 35902,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Action on presynaptic alpha-2 receptors</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline (epinephrine)</strong> is the drug of choice for the treatment of <strong>anaphylactic shock</strong>, primarily due to its effects on<strong> alpha-1, beta-1, and beta-2 adrenergic receptors. </strong>These actions include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-1 receptor</strong> stimulation, which causes <strong>vasoconstriction,</strong> critical for <strong>increasing blood pressure</strong> during the <strong>hypotensive </strong>state of <strong>anaphylactic shock.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-1 receptor</strong> stimulation, which leads to <strong>increased cardiac output</strong>, providing necessary<strong> cardiovascular support.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 receptor</strong> stimulation, essential for <strong>reversing bronchoconstriction</strong> and easing breathing in patients experiencing <strong>anaphylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The action on <strong>presynaptic alpha-2 receptors</strong> is <strong>not</strong> beneficial in <strong>anaphylactic shock.</strong> <strong>Alpha-2 receptors </strong>typically function to inhibit the release of <strong>norepinephrine (noradrenaline), </strong>acting as a<strong> negative feedback mechanism</strong>. In the setting of anaphylactic shock, <strong>inhibition of neurotransmitter </strong>release is<strong> counterproductive</strong>, as<strong> maximal sympathetic stimulation</strong> is required to counter the effects of <strong>anaphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bronchodilation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> by<strong> beta-2 receptors </strong>is vital for reversing <strong>airway constriction </strong>in <strong>anaphylaxis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cardiovascular</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> effects of<strong> beta-1 receptors </strong>are crucial for supporting <strong>heart function during shock</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vasoconstriction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> by<strong> alpha-1 receptors </strong>is necessary to<strong> counteract </strong>the profound <strong>vasodilation and hypotension</strong> seen in <strong>anaphylactic shock.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presynaptic alpha-2 receptor</strong> action of <strong>adrenaline,</strong> which would normally <strong>inhibit norepinephrine</strong> release and <strong>dampen</strong> <strong>sympathetic responses</strong>, is <strong>not </strong>desired in the treatment of <strong>anaphylactic shock</strong>, where a <strong>strong sympathetic </strong>response is needed to combat severe <strong>allergic reactions.</strong></span></span></span></p>",
      "correct_choice_id": 13190,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3313,
      "choices": [
        {
          "id": 13231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></span></p>"
        },
        {
          "id": 13232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride</span></span></span></p>"
        },
        {
          "id": 13233,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin</span></span></span></p>"
        },
        {
          "id": 13234,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testosterone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man came with urinary symptoms of increased frequency and hesitation. The patient was diagnosed with benign hyperplasia of prostate. Which of the drugs will help to prevent further growth and possibly reduces the size of the prostate? </span></span></span></p>",
      "unique_key": "Q1397598",
      "question_audio": null,
      "question_video": null,
      "map_id": 35903,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Finasteride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride is a <strong>5-alpha reductase inhibitor </strong>that reduces the conversion of <strong>testosterone to dihydrotestosterone (DHT)</strong>, which is a <strong>more potent androgen</strong> in the <strong>prostate gland</strong>. By<strong> lowering the levels of DHT, </strong>finasteride can prevent further <strong>growth of the prostate</strong> and potentially <strong>reduce its size.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tamsulosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This medication is an <strong>alpha-1A antagonist</strong> that <strong>relaxes the muscles </strong>in the<strong> prostate and bladder neck,</strong> <strong>improving urine flow,</strong> but<strong> does not</strong> affect<strong> prostate size. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Prazosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; While this <strong>non-selective alpha-1 antagonist</strong> can improve symptoms of<strong> benign prostatic hyperplasia (BPH</strong>) by <strong>relaxing prostate and bladder neck muscles, </strong>it <strong>doesn&#39;t reduce prostate size </strong>and is noted for <strong>causing postural hypotension. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Testosterone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Administration of testosterone can actually <strong>exacerbate BPH</strong> due to its <strong>conversion to DHT </strong>within the <strong>prostate, </strong>leading to<strong> further growth.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient diagnosed with <strong>BPH, finasteride </strong>is the <strong>drug of choice</strong> to not only <strong>alleviate urinary symptoms</strong> but also potentially <strong>reduce prostate size</strong> due to its mechanism of<strong> inhibiting the enzyme 5-alpha reductase</strong> and <strong>lowering intraprostatic DHT levels.</strong></span></span></span></p>",
      "correct_choice_id": 13232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3291,
      "choices": [
        {
          "id": 13143,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxazosin</span></span></span></p>"
        },
        {
          "id": 13144,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine</span></span></span></p>"
        },
        {
          "id": 13145,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></span></p>"
        },
        {
          "id": 13146,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following alpha-blocker drugs is used in the treatment of benign hypertrophy of the prostate without producing significant hypotension?</span></span></span></p>",
      "unique_key": "Q5843975",
      "question_audio": null,
      "question_video": null,
      "map_id": 35896,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Tamsulosin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tamsulosin </strong>is <strong>an alpha-1 receptor blocker </strong>with <strong>selectivity for the alpha-1A receptors</strong>, which are primarily located in the <strong>prostate</strong> <strong>and bladder neck.</strong> This <strong>selectivity </strong>allows <strong>tamsulosin to relax the smooth muscle </strong>in these areas, <strong>improving urinary flow </strong>and symptoms associated with <strong>benign prostatic hypertrophy (BPH) </strong>without significantly affecting <strong>vascular smooth muscle tone </strong>and thus <strong>minimizing </strong>the risk of <strong>hypotension</strong>. This characteristic makes<strong> tamsulosin </strong>particularly <strong>suitable </strong>for the treatment of<strong> BPH</strong>, providing <strong>symptomatic relief </strong>with a <strong>lower risk of cardiovascular side effects </strong>compared to <strong>non-selective alpha-blockers.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Doxazosin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxazosin is a<strong> non-selective alpha-1 antagonist. </strong>It is used to treat <strong>hypertension and BPH</strong>, but it <strong>does not </strong>have the same degree of selectivity for the<strong> alpha-1A receptors as tamsulosin </strong>and can cause more<strong> pronounced hypotension </strong>as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Phentolamine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine is a<strong> non-selective alpha-adrenergic antagonist</strong>, blocking both<strong> alpha-1 and alpha-2 receptors. </strong>It is primarily used in the management of<strong> hypertensive emergencies </strong>related to<strong> pheochromocytoma </strong>and is<strong> not </strong>commonly used in the treatment of <strong>BPH</strong>. Due to its <strong>non-selectivity, </strong>it can cause significant <strong>hypotension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Terazosin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin is another<strong> non-selective alpha-1 antagonist </strong>used to treat <strong>hypertension and symptoms of BPH</strong>. While it is effective in <strong>relieving urinary symptoms </strong>related to <strong>BPH,</strong> its<strong> non-selective</strong> action on<strong> alpha-1 receptors </strong>can also lead to more <strong>pronounced hypotension </strong>compared to <strong>tamsulosin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><strong><u> </u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tamsulosin,</strong> with its selectivity for <strong>alpha-1A receptors,</strong> is preferable for treating <strong>BPH symptoms</strong> as it <strong>minimizes </strong>the risk of <strong>hypotension</strong>. In contrast, <strong>non-selective alpha-blockers </strong>like<strong> doxazosin, terazosin, and phentolamine </strong>can be used in <strong>BPH </strong>but may have a<strong> higher risk </strong>of causing <strong>hypotension</strong>. </span></span></span></p>",
      "correct_choice_id": 13145,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3273,
      "choices": [
        {
          "id": 13071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyphylaxis</span></span></span></p>"
        },
        {
          "id": 13072,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinic actions of acetylcholine</span></span></span></p>"
        },
        {
          "id": 13073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biphasic response of adrenaline</span></span></span></p>"
        },
        {
          "id": 13074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasomotor reversal of Dale</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeated administration of a drug produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture1.jpg\" style=\"height:160px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2060792",
      "question_audio": null,
      "question_video": null,
      "map_id": 35892,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tachyphylaxis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a <strong>blood pressure tracing of a dog</strong>, with repeated administrations of a <strong>drug indicated by &#39;T&#39; (for Tyramine 0.3 mg/kg). </strong>The tracing shows<strong> successive spikes in blood pressure </strong>following each <strong>administration of the drug</strong>, with the<strong> magnitude of the spikes appearing to diminish over time</strong>. This <strong>phenomenon </strong>is known as <strong>tachyphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachyphylaxis </strong>refers to a <strong>rapidly decreasing response </strong>to a drug following its <strong>initial administration</strong>. In the context of the <strong>blood pressure tracing </strong>provided, it appears that the<strong> initial doses of Tyramine </strong>produce significant <strong>increases in blood pressure</strong>, but as <strong>more doses are administered, </strong>the effect becomes <strong>less pronounced. </strong>This is a classic characteristic of<strong> tachyphylaxis, </strong>where the <strong>body&#39;s response to a drug diminishes </strong>with <strong>repeated dosing over a short period.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Nicotinic actions of acetylcholine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is<strong> not </strong>the <strong>correct answer</strong>. The<strong> nicotinic actions</strong> of <strong>acetylcholine </strong>refer to the effect acetylcholine has on<strong> nicotinic acetylcholine</strong> <strong>receptors,</strong> which are<strong> ligand-gated ion channels</strong> found in the <strong>nervous system and at the neuromuscular junction</strong>. Normally <strong>acetylcholine decreases blood pressure and heart rate </strong>due to its action of <strong>muscarinic receptors. </strong>However, if we give <strong>very high dose of acetylcholine </strong>after giving <strong>atropine (to block muscarinic receptors), </strong>then it shows <strong>increase in BP and heart rate</strong>. This is due to the action of <strong>acetylcholine on nicotinic receptors</strong> present on <strong>ganglia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Biphasic response of adrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is<strong> incorrect. </strong>A <strong>biphasic response </strong>to<strong> adrenaline </strong>would involve an <strong>initial phase </strong>in which there is <strong>increase in blood pressure (due to stimulation of alpha 1 receptors) </strong>followed by a <strong>second phase </strong>in which there is fall in <strong>blood pressure (due to action on beta 2 receptors). </strong>The <strong>tracing does not </strong>show a <strong>biphasic response; </strong>it shows a <strong>series of responses </strong>that <strong>diminish over time, consistent </strong>with <strong>tachyphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vasomotor reversal of Dale</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vasomotor reversal of Dale </strong>is a phenomenon where <strong>adrenaline </strong>can produce a <strong>paradoxical decrease in blood pressure </strong>due to <strong>stimulation of vasodilatory beta-adrenergic receptors</strong>, especially after <strong>pre-treatment with drugs </strong>that <strong>block alpha-adrenergic receptors. </strong>This is <strong>not </strong>what is depicted in the tracing.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the image, the correct answer is:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyphylaxis is&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a <strong>diminishing response </strong>to <strong>repeated administrations </strong>of the same dose of a drug over a short period. This is a common pharmacological phenomenon often seen with drugs that<strong> act on receptors or other cellular targets </strong>that can become <strong>desensitized or down-regulated with frequent stimulation</strong>.</span></span></p>",
      "correct_choice_id": 13071,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3340,
      "choices": [
        {
          "id": 13339,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albuterol</span></span></span></p>"
        },
        {
          "id": 13340,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol</span></span></span></p>"
        },
        {
          "id": 13341,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipratropium</span></span></span></p>"
        },
        {
          "id": 13342,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudoephedrine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 66-year-old woman with a long history of heavy smoking presents to her doctor with complaints of shortness of breath and chronic coughing that has been present for about 2 years and has been worsening in frequency. The doctor decides to prescribe a bronchodilator agent that has minimal cardiac side effects, since the patient also has an extensive cardiac history. Which medication did the doctor likely prescribe? </span></span></span></p>",
      "unique_key": "Q6319845",
      "question_audio": null,
      "question_video": null,
      "map_id": 35889,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ipratropium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this scenario, the patient presents with symptoms consistent with <strong>chronic obstructive pulmonary disease (COPD),</strong> a common condition in<strong> long-term smokers.</strong> The doctor&#39;s decision to prescribe a<strong> bronchodilator with minimal cardiac side effects, </strong>given the <strong>patient&#39;s extensive cardiac history,</strong> points towards<strong> Ipratropium.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipratropium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>anticholinergic bronchodilator</strong> used in the <strong>management of COPD and asthma.</strong> It works by<strong> blocking</strong> <strong>muscarinic receptors </strong>in the<strong> airways, </strong>leading to<strong> bronchodilation.</strong> Importantly, it has<strong> minimal systemic absorption,</strong> which results in <strong>fewer cardiac side effects</strong> compared to <strong>other bronchodilators</strong> that act on <strong>beta-adrenergic receptor</strong>s. This makes it a <strong>suitable choice for patients</strong> with underlying <strong>cardiac conditions.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Albuterol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Albuterol is a<strong> beta-2 agonist </strong>that effectively <strong>relieves bronchoconstriction.</strong> However, it can have <strong>cardiac side effects </strong>such as <strong>tachycardia and palpitations</strong>, especially in patients with <strong>existing cardiac conditions,</strong> due to its <strong>slight action on beta-1 adrenergic receptors.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Atenolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Atenolol is a<strong> beta-1 selective blocker</strong> used primarily in the treatment of<strong> hypertension </strong>and other <strong>cardiovascular conditions</strong>. It is <strong>not a bronchodilator</strong> and would not be appropriate for the<strong> treatment of COPD or asthma.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pseudoephedrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pseudoephedrine is a <strong>sympathomimetic drug </strong>used as a <strong>decongestant.</strong> It can<strong> increase</strong> <strong>blood pressure </strong>and <strong>heart rate, </strong>making it <strong>unsuitable</strong> for a patient with an <strong>extensive cardiac history</strong> requiring <strong>bronchodilation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>selection of bronchodilators </strong>in the management of <strong>respiratory conditions like COPD, </strong>especially in patients with <strong>comorbid cardiac conditions.</strong> Recognizing the <strong>pharmacological profiles</strong> of <strong>different classes of bronchodilators </strong>and their <strong>systemic effects</strong> is crucial for <strong>minimizing adverse effects </strong>and <strong>optimizing patient care.</strong></span></span></span></p>",
      "correct_choice_id": 13341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3333,
      "choices": [
        {
          "id": 13311,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angina</span></span></span></p>"
        },
        {
          "id": 13312,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial atrioventricular block</span></span></span></p>"
        },
        {
          "id": 13313,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic hypertrophic subaortic cardiomyopathy</span></span></span></p>"
        },
        {
          "id": 13314,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial tremor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol is useful in the treatment of all of the following EXCEPT? </span></span></span></p>",
      "unique_key": "Q2019229",
      "question_audio": null,
      "question_video": null,
      "map_id": 35888,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Partial atrioventricular block</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is a <strong>non-selective beta blocker</strong>, which means it can <strong>block beta-1 and beta-2 adrenergic receptors.</strong> It is used in various <strong>cardiovascular and non-cardiovascular</strong> conditions due to <strong>its ability to slow heart rate,</strong> <strong>decrease myocardial oxygen demand, </strong>and <strong>reduce tremors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol</strong> is <strong>contraindicated </strong>in patients with<strong> partial atrioventricular block </strong>as it can exacerbate the condition leading to <strong>complete heart block</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Angina:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol </strong>is used in the management of<strong> angina pectoris</strong> due to its <strong>ability to reduce myocardial oxygen demand</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Idiopathic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>hypertrophic subaortic cardiomyopathy (HOCM):</strong> Beta blockers like <strong>propranolol </strong>are used in<strong> HOCM to reduce</strong> the <strong>outflow obstruction </strong>and <strong>improve symptoms. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial tremor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Propranolol</strong> is effective in<strong> reducing tremors </strong>in conditions like<strong> familial or essential tremor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is <strong>contraindicated</strong> in patients with<strong> partial atrioventricular block </strong>as it can <strong>exacerbate the condition </strong>leading to <strong>complete</strong> <strong>heart block.</strong> It is, however, <strong>beneficial</strong> in conditions such as<strong> angina, HOCM, and familial tremors</strong>. Patients with <strong>variant angina</strong> <strong>(Prinzmetal&#39;s angina)</strong> <strong>should not&nbsp;</strong>&nbsp;be treated with <strong>propranolol due to the risk of coronary vasospasm.</strong></span></span></p>",
      "correct_choice_id": 13312,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3301,
      "choices": [
        {
          "id": 13183,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
        },
        {
          "id": 13184,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopexamine</span></span></span></p>"
        },
        {
          "id": 13185,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
        },
        {
          "id": 13186,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a catecholamine, that can stimulate D1, D2, alpha 1 and &beta;-1 receptors, but not &beta;-2 receptors? </span></span></p>",
      "unique_key": "Q1403857",
      "question_audio": null,
      "question_video": null,
      "map_id": 35901,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dopamine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine</strong> is a<strong> catecholamine neurotransmitter and hormone </strong>that exhibits activity on<strong> both dopaminergic and adrenergic receptors.</strong> It specifically<strong> stimulates D1 and D2 dopamine receptors</strong>, which are primarily involved in <strong>neurological functions </strong>and <strong>renal vasodilation</strong>, and <strong>&alpha;1 and &beta;1 adrenergic receptors,</strong> which mediate <strong>vasoconstriction and increase heart rate and contractility,</strong> respectively. Importantly, <strong>dopamine does not </strong>act on <strong>&beta;2 adrenergic receptors, </strong>which are mainly responsible for<strong> bronchodilation and vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121213.jpg\" style=\"height:435px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong><u>&nbsp;</u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine</strong> is the <strong>catecholamine</strong> that meets the criteria of stimulating <strong>D1, D2, &alpha;1, and &beta;1 receptors </strong>without affecting <strong>&beta;2 receptors</strong>, which is particularly relevant in treating certain <strong>cardiovascular conditions</strong> where <strong>selective receptor </strong>activation is <strong>desired</strong></span></span></span></p>",
      "correct_choice_id": 13185,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3320,
      "choices": [
        {
          "id": 13259,
          "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></p>"
        },
        {
          "id": 13260,
          "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinine </span></span></p>"
        },
        {
          "id": 13261,
          "text": "<p style=\"margin-right:-1px\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine </span></span></p>"
        },
        {
          "id": 13262,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After eating a plant as shown in the figure below, A child presented to emergency in comatose state. The pupils were dilated, and skin was dry. Body temperature is raised, and heart rate is high. These signs and symptoms can occur with the intake of which of the following substance?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture3_XXE4pf8.jpg\" style=\"height:182px; width:300px\" /></span></span></p>",
      "unique_key": "Q5170375",
      "question_audio": null,
      "question_video": null,
      "map_id": 35906,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Atropine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>signs and symptoms</strong> described are characteristic of <strong>atropine poisoning,</strong> which include <strong>dilated pupils (mydriasis), dry skin,</strong> <strong>elevated body temperature (hyperthermia), and tachycardia.</strong> The <strong>plant </strong>identified as the <strong>source of atropine</strong> in this case is <strong>Datura</strong> <strong>stramonium.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &nbsp;Morphine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>- Incorrect,</strong> as morphine typically causes <strong>constricted pupils (miosis), </strong>not dilation. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Quinine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect,</strong> as quinine is <strong>not</strong> commonly associated with <strong>these symptoms. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Digoxin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect, </strong>as <strong>digoxin overdose</strong> typically <strong>does not cause hyperthermia</strong> and <strong>dry skin</strong> but can cause other symptoms such as <strong>nausea, vomiting, and heart rhythm disturbances.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> DHATURA acronym</strong> can be used to remember the<strong> signs of atropine poisoning: Dry mouth and Delirium, Hyperthermia, Agitation, Tachycardia, Urinary retention, Retention of stool, and lost Accommodation (dilated pupils, photophobia, blurred vision).</strong></span></span></span></p>",
      "correct_choice_id": 13261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3278,
      "choices": [
        {
          "id": 13091,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By decreasing the rate of diastolic depolarization of SA node</span></span></span></p>"
        },
        {
          "id": 13092,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By causing delay through AV node</span></span></span></p>"
        },
        {
          "id": 13093,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By blocking calcium channels and prolonging the plateau phase</span></span></span></p>"
        },
        {
          "id": 13094,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By reducing the rate of ventricular repolarization</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetylcholine decrease heart rate by which of the following mechanisms?</span></span></span></p>",
      "unique_key": "Q8824422",
      "question_audio": null,
      "question_video": null,
      "map_id": 35894,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) By decreasing the rate of diastolic depolarization of SA node</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetylcholine, </strong>when acting on the<strong> heart, </strong>primarily affects the<strong> muscarinic receptors. </strong>The effect of <strong>acetylcholine on heart rate</strong> is known as the<strong> parasympathetic or vagal effect</strong>, which <strong>slows the heart rate</strong>. Spontaneous d<strong>iastolic depolarization (Phase 4 of action</strong> <strong>potential) of sinoatrial (SA) node</strong> is required for a<strong>utomaticity of SA node. </strong>Acetylcholine acts on the node to <strong>decrease the slope of phase 4</strong>. This action slows the <strong>rate of spontaneous depolarization </strong>and,<strong> consequently, decreases the heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By<strong> decreasing the rate </strong>of <strong>diastolic depolarization of SA node</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This action on the <strong>SA node slows the pacemaker activity,</strong> thereby <strong>decreasing the heart rate,</strong> which is the primary mechanism by which <strong>acetylcholine </strong>exerts its<strong> negative chronotropic effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. By causing delay through AV node:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>While acetylcholine</strong> does cause a <strong>delay in conduction </strong>through the <strong>atrioventricular (AV) node, </strong>this is<strong> not</strong> the primary mechanism by which it<strong> decreases the heart rate.</strong> However, this effect can contribute to a <strong>reduction in the ventricular rate</strong>, especially during conditions such as <strong>atrial fibrillation,</strong> by <strong>limiting the number of impulses t</strong>hat reach the<strong> ventricles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. By blocking calcium channels and prolonging the plateau phase:</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>option is incorrect </strong>with respect to<strong> heart rate</strong>. <strong>Blocking calcium channels</strong> and <strong>prolonging the plateau phase</strong> of the<strong> cardiac action potential </strong>would affect the<strong> force of cardiac muscle</strong> <strong>contraction </strong>and potentially the <strong>duration of the action potential,</strong> but it is <strong>not </strong>the primary mechanism by which<strong> acetylcholine decreases heart rate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. By reducing the rate of ventricular repolarization:&nbsp;</span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This mechanism is <strong>not </strong>associated with <strong>acetylcholine</strong>. Acetylcholine <strong>does not </strong>typically <strong>reduce the rate of ventricular repolarization; </strong>instead, it would affect the <strong>repolarization phase of the atria more </strong>than the <strong>ventricles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aetylcholine decreases heart rate</strong> by <strong>decreasing the rate of diastolic depolarization of the SA node</strong>, which <strong>reduces </strong>the frequency of <strong>action potentials generated </strong>and hence<strong> lowers the heart rate</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8th/114</span></strong></span></span></p>",
      "correct_choice_id": 13091,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3292,
      "choices": [
        {
          "id": 13147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propranolol</span></span></span></p>"
        },
        {
          "id": 13148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Timolol</span></span></span></p>"
        },
        {
          "id": 13149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Betaxolol</span></span></span></p>"
        },
        {
          "id": 13150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Levobunolol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following beta-blockers can be used in glaucoma except? </span></span></span></p>",
      "unique_key": "Q2468688",
      "question_audio": null,
      "question_video": null,
      "map_id": 35897,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) &nbsp;Propranolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta blockers </strong>with <strong>membrane stabilizing property </strong>should be<strong> avoided in glaucoma</strong>.</span></em></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is a <strong>non-selective beta-adrenergic receptor blocker </strong>widely used for its<strong> cardiovascular effects</strong>, such as treating <strong>hypertension, angina pectoris, </strong>and certain types of <strong>arrhythmias</strong>. Unlike the<strong> beta-blockers </strong>commonly employed in the treatment of <strong>glaucoma,</strong> <strong>propranolol lacks the specific ocular advantages </strong>provided by others, notably<strong> its absence in the standard management of glaucoma. </strong>A critical distinction is its<strong> membrane-stabilizing activity, </strong>which can lead to<strong> corneal anesthesia, </strong>making it <strong>less suitable </strong>for <strong>ocular applications</strong>. This property can potentially interfere with <strong>corneal health by reducing its sensitivity</strong>, thereby<strong> increasing the risk </strong>of <strong>corneal injuries </strong>going unnoticed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Timolol:</strong> Timolol is a <strong>non-selective beta-blocker</strong> effectively used in <strong>glaucoma</strong> treatment by <strong>lowering intraocular pressure</strong> through <strong>decreased aqueous humor production</strong>. <strong>Unlike propranolol,</strong> <strong>timolol </strong>is preferred for<strong> ocular use </strong>due to its <strong>minimal systemic</strong> <strong>side effects</strong> and<strong> lack of significant membrane-stabilizing activity</strong> that could lead to <strong>corneal anesthesia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Betaxolol: </strong>&nbsp;Betaxolol is a <strong>beta-1 selective adrenergic receptor blocker</strong>. Its selectivity is <strong>beneficial </strong>in patients with <strong>respiratory issues, </strong>as it minimally affects <strong>beta-2 receptors associated with bronchial smooth muscle</strong>. <strong>Betaxolol </strong>is used in<strong> glaucoma</strong> treatment to <strong>reduce intraocular pressure</strong> and is noted for having<strong> less membrane-stabilizing activity </strong>compared to <strong>non-selective beta-blockers</strong>, making it safer for the cornea.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Levobunolol:</strong> Levobunolol is another <strong>non-selective beta-blocker </strong>used for<strong> <em>lowering intraocular pressure </em>in glaucoma</strong> patients. It shares <strong>similar benefits with timolol</strong> in terms of <strong>efficacy </strong>in glaucoma treatment and has a l<strong>ow risk of causing corneal</strong> <strong>anesthesia </strong>due to its <strong>minimal membrane-stabilizing effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While<strong> timolol, betaxolol, and levobunolol </strong>are suitable to be used in <strong>glaucoma </strong>due to their specific <strong>ocular effects </strong>and <strong>minimal membrane-stabilizing activity</strong>, <strong>propranolol </strong>is <strong>not </strong>commonly used in<strong> glaucoma </strong>due to its <strong>non-selective action </strong>and <strong>potential </strong>for causing <strong>corneal anesthesia</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-blockers with Membrane Stabilizing Activity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These drugs possess Na+ channel blocking (local anesthetic) activity. It can contribute to anti-arrhythmic action.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These drugs should be avoided in glaucoma due to the risk of corneal anesthesia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Examples</strong>: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ossess:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>P</strong>ropranolol (maximum)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Me</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">mbrane stabilizing or: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Me</strong>toprolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ocal: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<strong>L</strong>abetalol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">naesthetic: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<strong>A</strong>cebutolol</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">roperty: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<strong>P</strong>indolol</span></span></span></p>",
      "correct_choice_id": 13147,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3293,
      "choices": [
        {
          "id": 13151,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less bronchoconstriction</span></span></span></p>"
        },
        {
          "id": 13152,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less adverse effect on lipid profile</span></span></span></p>"
        },
        {
          "id": 13153,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Less likely to cause glucose intolerance</span></span></span></p>"
        },
        {
          "id": 13154,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Properties making cardio-selective beta-blockers desirable are?</span></span></p>",
      "unique_key": "Q4150061",
      "question_audio": null,
      "question_video": null,
      "map_id": 35898,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardio-selective beta-blockers,</strong> also known as <strong>beta-1 selective blockers,</strong> are designed to preferentially <strong>block beta-1 adrenergic</strong> <strong>receptors </strong>located primarily in the <strong>heart. </strong>This specificity confers several advantages in clinical use, including:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less bronchoconstriction:&nbsp;</strong>By selectively targeting <strong>beta-1 receptors and sparing beta-2 receptors </strong>(which<strong> mediate bronchial smooth muscle relaxation), cardio-selective beta-blockers</strong> <strong>reduce </strong>the risk of <strong>bronchoconstriction</strong>. This makes them a safer option for patients with respiratory conditions such as <strong>asthma or chronic obstructive pulmonary disease (COPD).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less adverse effect on lipid profile:&nbsp;Cardio-selective beta-blockers</strong> are less likely to <strong>negatively impact lipid metabolism. Non-selective beta-blockers </strong>can <strong>increase triglycerides and decrease HDL cholesterol</strong>. <strong>Cardio-selective </strong>agents have a lesser effect on these parameters, making them a preferable <strong>choice for patients </strong>with or at <strong>risk for metabolic syndrome</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less likely to cause glucose intolerance:&nbsp;Non-selective beta-blockers</strong> can <strong>impair insulin sensitivity </strong>and mask symptoms of <strong>hypoglycemia,</strong> which is a concern for <strong>diabetic patients</strong>. <strong>Cardio-selective beta-blockers </strong>have a <strong>reduced impact on glucose metabolism </strong>and are, therefore, considered a better option for patients with <strong>diabetes </strong>or those at <strong>risk for glucose intolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The benefits of <strong>cardio-selective beta-blockers </strong>over<strong> non-selective beta-blockers </strong>include: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lower propensity</strong> to cause <strong>bronchoconstriction.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less interference</strong> with<strong> carbohydrate metabolism</strong> and <strong>safer in diabetes mellitus. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less chances</strong> of precipitating<strong> Raynaud&rsquo;s phenomenon.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>No deleterious effect</strong> on <strong>blood lipid profile.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ineffective</strong> in <strong>suppressing essential tremor</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less liable</strong> to<strong> impair exercise capacity.</strong></span></span></li>\r\n</ul>",
      "correct_choice_id": 13154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3296,
      "choices": [
        {
          "id": 13163,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylalanine hydroxylase</span></span></span></p>"
        },
        {
          "id": 13164,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tyrosine hydroxylase</span></span></span></p>"
        },
        {
          "id": 13165,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopa Decarboxylase</span></span></span></p>"
        },
        {
          "id": 13166,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine &beta; hydroxylase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rate limiting step in catecholamine synthesis is?</span></span></p>",
      "unique_key": "Q3332473",
      "question_audio": null,
      "question_video": null,
      "map_id": 35899,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Ans. B) Tyrosine hydroxylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Catecholamine synthesis </strong>involves several <strong>enzymatic </strong>steps, starting from the <strong>amino acid tyrosine</strong>. The<strong> rate-limiting step </strong>of this pathway is the <strong>hydroxylation of tyrosine </strong>to form <strong>dihydroxyphenylalanine (DOPA), </strong>which is <strong>catalyzed </strong>by the enzyme <strong>tyrosine hydroxylase</strong>. This <strong>enzyme&#39;s activity </strong>is the primary control point for the <strong>production of catecholamines</strong>, which include <strong>dopamine, norepinephrine, and epinephrine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synthesis Pathway:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosine </strong>is <strong>hydroxylated by tyrosine hydroxylase </strong>in the presence of<strong> tetrahydrobiopterin (THB) </strong>to form <strong>DOPA</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>DOPA </strong>is then <strong>decarboxylated by DOPA decarboxylase</strong>, which requires<strong> vitamin B6</strong>, to form<strong> dopamine</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine </strong>is converted to <strong>norepinephrine </strong>by<strong> dopamine &beta; hydroxylase</strong>, with<strong> vitamin C </strong>as a <strong>cofactor.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Norepinephrine</strong> is further <strong>methylated </strong>to form<strong> epinephrine </strong>in the <strong>adrenal medulla by phenylethanolamine N-methyltransferase</strong>, which uses <strong>S-adenosyl methionine </strong>as a<strong> methyl donor.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Phenylalanine hydroxylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Not the rate-limiting </strong>step in <strong>catecholamine synthesis,</strong> but it is involved in the <strong>conversion of</strong> <strong>phenylalanine to tyrosine. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dopa Decarboxylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Catalyzes the conversion of DOPA to dopamine </strong>but is not the rate-limiting step. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Dopamine &beta; hydroxylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Converts dopamine to norepinephrine,</strong> not the rate-limiting step in catecholamine synthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosine hydroxylase </strong>is the<strong> rate-limiting enzyme </strong>in the synthesis of<strong> catecholamines</strong>, determining the <strong>overall rate </strong>at which these critical <strong>neurotransmitters and hormones</strong> are produced in the body.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture21_jXwtz1W.jpg\" style=\"height:663px; width:400px\" /></span></span></span></p>",
      "correct_choice_id": 13164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3299,
      "choices": [
        {
          "id": 13175,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></span></p>"
        },
        {
          "id": 13176,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine</span></span></span></p>"
        },
        {
          "id": 13177,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
        },
        {
          "id": 13178,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs acting on dilator pupillae has an action analogous to that of pilocarpine on sphincter pupillae?</span></span></span></p>",
      "unique_key": "Q4086012",
      "question_audio": null,
      "question_video": null,
      "map_id": 35900,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Phenylephrine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the Question:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sphincter pupillae contains M3 receptors</strong>, <strong>pilocarpine stimulate </strong>these <strong>receptors</strong> and result in <strong>miosis</strong>. Therefore, action of <strong>pilocarpine of sphincter pupillae </strong>is to stimulate it. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Analogous</strong> means <strong>functionally similar</strong>. So <strong>analogous action on dilator pupillae</strong> means to stimulate<strong> dilator pupillae.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, the question is that which drug stimulate dilator pupillae.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Concept:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sphincter pupillae contains M3 receptors</strong>. Thus, <strong>cholinergic drugs </strong>like <strong>pilocarpine, physostigmine </strong>etc <strong>stimulate </strong>these <strong>receptors </strong>resulting in <strong>miosis</strong>. This is called <strong>active miosis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dilator pupillae </strong>contains<strong> Alpha 1 receptors</strong>. Thus, <strong>adrenergic </strong>drugs like <strong>epinephrine, phenylephrine etc</strong>. <strong>stimulate </strong>these receptors resulting in<strong> mydriasis</strong>. This is called <strong>active mydriasis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>M3 blockers </strong>like<strong> atropine</strong>, <strong>tropicamide </strong>etc cause <strong>unopposed </strong>stimulation of <strong>dilator pupillae </strong>resulting in <strong>passive mydriasis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha 1 blockers</strong> may result in<strong> unopposed stimulation of sphincter pupillae </strong>leading to <strong>passive miosis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>sympathomimetic drug</strong> that acts as an <strong>alpha-adrenergic agonis</strong>t. When applied <strong>topically </strong>to the eye, it <strong>stimulates the dilator pupillae muscle</strong>, causing <strong>pupillary dilation (mydriasis)</strong>. This action is <strong>analogous </strong>to that of <strong>pilocarpine on the sphincter pupillae</strong>.<strong> Pilocarpine</strong> is a<strong> cholinergic agonist</strong> that contracts the <strong>sphincter pupillae muscle,</strong> resulting in <strong>pupillary constriction (miosis).</strong> <strong>Both drugs </strong>have direct actions on their <strong>respective target muscles in the iris,</strong> but they produce <strong>opposite effects: phenylephrine causes dilation</strong>, while <strong>pilocarpine causes constriction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Timolol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol is a n<strong>on-selective beta-adrenergic receptor blocker</strong> used in the treatment of <strong>glaucoma to lower</strong> <strong>intraocular pressure. </strong>It <strong>does not</strong> have a direct effect on the <strong>muscles of the iris </strong>and thus <strong>does not cause analogous action</strong> to <strong>pilocarpine on sphincter pupillae.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neostigmine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine is a <strong>cholinesterase inhibitor </strong>that<strong> increases the concentration of acetylcholine</strong> at <strong>cholinergic</strong> <strong>synapses</strong>, indirectly causing <strong>miosis</strong> by enhancing the effect of <strong>acetylcholine on the sphincter pupillae</strong>. Its mechanism of action is indirect, unlike the <strong>direct action of phenylephrine on the dilator pupillae.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tropicamide:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide is an <strong>anticholinergic agent </strong>used as a <strong>mydriatic to dilate the pupil.</strong> It works by <strong>blocking</strong> <strong>muscarinic receptors </strong>in the <strong>sphincter pupillae, preventing acetylcholine from contracting the muscle</strong>. While tropicamide does cause <strong>pupillary dilation,</strong> its mechanism <strong>(antagonism of cholinergic action) </strong>is<strong> not analogous</strong> to the direct<strong> stimulatory effect of pilocarpine</strong> <strong>on the sphincter pupillae</strong>. <strong>Phenylephrine&#39;s </strong>direct<strong> agonistic</strong> action on the <strong>dilator pupillae </strong>makes it the analogous agent.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenylephrine, a sympathomimetic agent,</strong> directly stimulates the <strong>dilator pupillae to cause dilation, </strong>serving as an<strong> analogous action</strong> to <strong>pilocarpine&#39;s</strong> stimulation of the <strong>sphincter pupillae</strong> to cause <strong>constriction. </strong></span></span></p>",
      "correct_choice_id": 13176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3316,
      "choices": [
        {
          "id": 13243,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenergic receptor antagonist</span></span></span></p>"
        },
        {
          "id": 13244,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor antagonist</span></span></span></p>"
        },
        {
          "id": 13245,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histaminic antagonist</span></span></span></p>"
        },
        {
          "id": 13246,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonergic antagonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxybutynin is a drug used for treatment of overactive bladder. It acts as?&nbsp; </span></span></span></p>",
      "unique_key": "Q6204649",
      "question_audio": null,
      "question_video": null,
      "map_id": 35904,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Muscarinic receptor antagonist</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxybutynin </strong>acts as a <strong>muscarinic receptor antagonist.</strong> It specifically <strong>targets muscarinic receptors </strong>in the <strong>urinary bladder and salivary</strong> <strong>glands</strong>, making it <strong>effective in treating</strong> conditions like <strong>detrusor overactivity</strong>, which causes symptoms such as <strong>urinary frequency and</strong> <strong>urge incontinence.</strong> By <strong>blocking</strong> the <strong>action of acetylcholine</strong> on these receptors, <strong>oxybutynin helps</strong> to <strong>relax the bladder muscle</strong> (<strong>detrusor) and increase bladder capacity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option A.&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenergic receptor antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp; Incorrect </strong>because<strong> oxybutynin does not </strong>primarily act on <strong>adrenergic receptors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Histaminic antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect </strong>as <strong>oxybutynin</strong> <strong>does not</strong> <strong>block histamine receptors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Serotonergic antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect</strong> since <strong>oxybutynin</strong> is<strong> not </strong>known to<strong> antagonize serotonergic receptors</strong> in the context of <strong>overactive bladder treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember that <strong>oxybutynin is a muscarinic receptor antagonist </strong>used in the treatment of <strong>overactive bladder</strong> due to its <strong>selective</strong> <strong>action on M1 and M3 muscarinic subtypes,</strong> which provides <strong>therapeutic benefits</strong> in conditions like<strong> detrusor instability and</strong> <strong>neurogenic bladder.</strong></span></span></span></p>",
      "correct_choice_id": 13244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3319,
      "choices": [
        {
          "id": 13255,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apraclonidine</span></span></span></p>"
        },
        {
          "id": 13256,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></span></p>"
        },
        {
          "id": 13257,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost</span></span></span></p>"
        },
        {
          "id": 13258,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs used in treatment of glaucoma is an alpha-2-agonist? </span></span></span></p>",
      "unique_key": "Q3991841",
      "question_audio": null,
      "question_video": null,
      "map_id": 35905,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Apraclonidine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apraclonidine </strong>is an<strong> alpha-2 adrenergic receptor agonist</strong> used in the treatment of <strong>glaucoma.</strong> It works by <strong>reducing the production of</strong> <strong>aqueous humor and increasing its outflow </strong>through the<strong> trabecular meshwork.</strong> By <strong>stimulating alpha-2 receptors, apraclonidine</strong> <strong>decreases</strong> the<strong> synthesis and secretion of aqueous humor,</strong> thereby <strong>lowering intraocular pressure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Timolol:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol is a <strong>non-selective beta-adrenergic receptor blocker (beta-blocker)</strong> used in the <strong>treatment</strong> <strong>of glaucoma.</strong> It works by<strong> reducing the production of aqueous humor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Latanoprost:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost is a<strong> prostaglandin analog </strong>used in the <strong>treatment of glaucoma.</strong> It works by <strong>increasing the outflow</strong> of <strong>aqueous humor</strong> through the <strong>uveoscleral pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Netarsudil:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil is a <strong>rho kinase inhibitor </strong>used in the treatment of <strong>glaucoma</strong>. It works by <strong>increasing the outflow of</strong> <strong>aqueous humor</strong> through the <strong>trabecular meshwork and Schlemm&#39;s canal.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apraclonidine,</strong> as an <strong>alpha-2 adrenergic receptor agonist,</strong> <strong>reduces intraocular pressure </strong>by<strong> decreasing</strong> the production of <strong>aqueous</strong> <strong>humor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121842.jpg\" style=\"height:315px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 13255,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3329,
      "choices": [
        {
          "id": 13295,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Carvedilol &ndash; &beta;<sub>2</sub> agonistic activity </span></span></span></p>"
        },
        {
          "id": 13296,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Celiprolol &ndash; Potassium channel blocker </span></span></span></p>"
        },
        {
          "id": 13297,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lebetalol &ndash; Calcium channel blocker</span></span></span></p>"
        },
        {
          "id": 13298,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Nebivolol &ndash; Enhance NO production </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following match of a 3<sup>rd</sup> generation beta blocker with its mechanism of vasodilatory property is correct? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q4619082",
      "question_audio": null,
      "question_video": null,
      "map_id": 35887,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Nebivolol: Enhance NO production </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Third generation beta blockers are any of the beta blockers (either first generation or second generation) that possess additional vasodilatory property.&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nebivolol is classified as a <strong>third-generation beta-blocker</strong> because it has additional <strong>vasodilatory effects</strong> due to its ability to<strong> increase</strong> the <strong>production of nitric oxide (NO) </strong>from the <strong>endothelium</strong>, which leads to <strong>vasodilation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Carvedilol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>because <strong>carvedilol has alpha-blocking properties </strong>as well as <strong>antioxidant properties</strong> that contribute to its<strong> vasodilatory effects</strong>, <strong>not &beta;2 agonistic activity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Celiprolol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect</strong> because <strong>celiprolol </strong>has some<strong> &beta;2 agonistic effects</strong> which may contribute to its <strong>vasodilatory properties,</strong> <strong>not potassium channel blocking. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Labetalol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>because l<strong>abetalol blocks both alpha and beta receptors</strong> but <strong>does not act</strong> as a <strong>calcium channel</strong> <strong>blocker.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nebivolol&#39;s</strong> mechanism of<strong> vasodilation</strong> is distinct among<strong> beta blockers </strong>because it enhances <strong>nitric oxide production,</strong> leading to <strong>vasodilation without </strong>the <strong>typical resistance </strong>seen with <strong>pure beta-blocking effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of vasodilation in third generation beta blockers </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-11-165735.jpg\" style=\"height:200px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 13298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3354,
      "choices": [
        {
          "id": 13395,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of benzalkonium bromide in the preparation</span></span></span></p>"
        },
        {
          "id": 13396,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prejunctional M2 receptor stimulation</span></span></span></p>"
        },
        {
          "id": 13397,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated use of hypertonic saline in nebulizer</span></span></span></p>"
        },
        {
          "id": 13398,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of EDTA as impurity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following can be the mechanism for paradoxical bronchoconstriction seen with the use of ipratropium bromide Except?</span></span></span></p>",
      "unique_key": "Q3513814",
      "question_audio": null,
      "question_video": null,
      "map_id": 35891,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Prejunctional M2 receptor stimulation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prejunctional M2 receptors:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Their activation typically <strong>inhibits the release of acetylcholine,</strong> contributing to <strong>bronchodilation. Ipratropium, </strong>as an <strong>anticholinergic agent</strong>, <strong>would not </strong>stimulate but <strong>block M2 receptors,</strong> potentially leading to<strong> increased release of acetylcholine</strong> and resulting in<strong> bronchoconstriction</strong> in some patients. This mechanism is <strong>not</strong> usually the c<strong>ause of paradoxical bronchoconstriction </strong>observed with <strong>ipratropium,</strong> making it the exception among the options provided.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Benzalkonium bromide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>preservative</strong> in some<strong> inhaler formulation</strong>s, which can cause <strong>airway irritation and</strong> <strong>constriction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypertonic saline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Can also cause <strong>bronchoconstriction</strong> due to its <strong>osmotic effects on the airway.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. EDTA:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Can act as an <strong>irritant </strong>leading to <strong>bronchoconstriction </strong>when included as an <strong>impurity in the formulation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>ipratropium bromide</strong> is typically used for its <strong>bronchodilatory effects, </strong>certain <strong>excipients or impurities </strong>in the formulation, like <strong>benzalkonium bromide or EDTA, </strong>as well as associated use of <strong>hypertonic saline,</strong> can lead to<strong> paradoxical bronchoconstriction.</strong> However,<strong> prejunctional M2 receptor stimulation</strong> would<strong> no</strong>t be the <strong>correct mechanism</strong> for this<strong> adverse effect</strong>, as <strong>ipratropium would</strong> <strong>block </strong>rather than stimulate these receptors.</span></span></span></p>",
      "correct_choice_id": 13396,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}